Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Food and Drug Law Journal|March 20, 2014
United States v. Caronia: The increasing strength of commercial free speech and potential new emphasis on classifying off-label promotion as "false and misleading"Marc J Scheineson, Guillermo Cuevas
Open Forum Infectious Diseases|September 27, 2017
Infliximab Biosimilars: A Promising but Unusual Treatment for Mycobacterial Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected PatientsJesús Troya, Guillermo Cuevas, Pablo Ryan, et al.
AIDS (London, England)|March 22, 2018
High HIV seroconversion rate in hepatitis C virus-infected drug users followed in a harm reduction unit: a lost opportunity for preexposure prophylaxisJorge Valencia, Pablo Ryan, Alejandro Alvaro-Meca, et al.
Plos One|October 4, 2018
HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV eliminationJorge Valencia La Rosa, Pablo Ryan, Alejandro Alvaro-Meca, et al.
International Journal of STD & AIDS|July 7, 2020
Health care issues affecting transgender people living with HIV: an opportunity for improvementJesús Troya, Jorge Del Romero, Pablo Ryan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 22, 2026
HIV/HCV prevalence and the retention paradox in marginalized populations in Madrid (2019-2023): A large-scale cross-sectional studyJorge Valencia, Pablo Ryan, Helena Codina, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 12, 2021
Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-careJorge Valencia, Jeffrey V Lazarus, Francisco C Ceballos, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 19, 2024
Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: a retrospective studyPablo Ryan, Jorge Valencia, Guillermo Cuevas, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 17, 2018
Alternative switching strategies based on regimens with a low genetic barrier: do clinicians have a choice nowadays?Jesús Troya, Pablo Ryan, Rocío Montejano, et al.
AIDS Care|September 6, 2021
Effectiveness of an HIV care model integrated into addiction care based on medication-assisted treatment for HIV-positive people who use drugsJorge Valencia, Jesús Troya, Jeffrey V Lazarus, et al.
Pageof 5